An Inducible Pathway for Degradation of FLIP Protein Sensitizes Tumor Cells to TRAIL-induced Apoptosis *

作者: Youngsoo Kim , Nanjoo Suh , Michael Sporn , John C. Reed

DOI: 10.1074/JBC.M202458200

关键词:

摘要: TRAIL (Apo2 ligand) is a member of the tumor necrosis factor (TNF) family cytokines that induces apoptosis. Because preferentially kills cells, sparing normal tissues, interest has emerged in applying this biological for cancer therapy humans. However, not all tumors respond to TRAIL, raising questions about resistance mechanisms. We demonstrate here variety natural and synthetic ligands peroxisome proliferator-activated receptor-γ (PPARγ) sensitize but cells apoptosis induction by TRAIL. PPARγ selectively reduce levels FLIP, an apoptosis-suppressing protein blocks early events TRAIL/TNF death receptor signaling. Both agonists antagonists displayed these effects, regardless expression even presence dominant-negative mutant, indicating PPARγ-independent mechanism. Reductions FLIP sensitization TRAIL-induced were also correlated with NF-κB, further suggesting novel modulators induced ubiquitination proteasome-dependent degradation without concomitant reductions mRNA. The findings suggest existence pharmacologically regulated target class drugs controls turnover, raise possibility combining more efficacious elimination through

参考文章(56)
Ajay Chawla, Yaacov Barak, Laszlo Nagy, Debbie Liao, Peter Tontonoz, Ronald M. Evans, PPAR-gamma dependent and independent effects on macrophage-gene expression in lipid metabolism and inflammation. Nature Medicine. ,vol. 7, pp. 48- 52 ,(2001) , 10.1038/83336
Wen-Hui Hu, Holly Johnson, Hong-Bing Shu, Activation of NF-κB by FADD, Casper, and Caspase-8 Journal of Biological Chemistry. ,vol. 275, pp. 10838- 10844 ,(2000) , 10.1074/JBC.275.15.10838
Shigekazu Nagata, Steering anti-cancer drugs away from the TRAIL Nature Medicine. ,vol. 6, pp. 502- 503 ,(2000) , 10.1038/74972
Quinn L. Deveraux, Ryosuke Takahashi, Guy S. Salvesen, John C. Reed, X-linked IAP is a direct inhibitor of cell-death proteases Nature. ,vol. 388, pp. 300- 304 ,(1997) , 10.1038/40901
David J. Mangelsdorf, Ethan Dmitrovsky, Gordon W. Gribble, Robert A. Maue, Kathleen C. Flanders, Kotha Subbaramaiah, Michael J. Spinella, Carl F. Nathan, Weston W. Porter, William F. Hickey, Donna M. Porter, Anita B. Roberts, Nanjoo Suh, Yongping Wang, Andrew E. Place, Michael B. Sporn, Andrew J. Dannenberg, John J. Letterio, Tadashi Honda, Nanette S. Roche, Lananh Nguyen, Gengfei Wu, Renee F. Ren, Charlotte R. Williams, A Novel Synthetic Oleanane Triterpenoid, 2-Cyano-3,12-dioxoolean-1,9-dien-28-oic Acid, with Potent Differentiating, Antiproliferative, and Anti-Inflammatory Activity Cancer Research. ,vol. 59, pp. 336- 341 ,(1999)
Minji Jo, Tae-Hyoung Kim, Dai-Wu Seol, James E. Esplen, Kenneth Dorko, Timothy R. Billiar, Stephen C. Strom, Apoptosis induced in normal human hepatocytes by tumor necrosis factor-related apoptosis-inducing ligand Nature Medicine. ,vol. 6, pp. 564- 567 ,(2000) , 10.1038/75045
Peter H. Krammer, CD95's deadly mission in the immune system Nature. ,vol. 407, pp. 789- 795 ,(2000) , 10.1038/35037728
Bert Vogelstein, David Lane, Arnold J. Levine, Surfing the p53 network Nature. ,vol. 408, pp. 307- 310 ,(2000) , 10.1038/35042675
C. K. Mirabelli, H. Chan, Ming-Yi Chiang, J. E. E. Shoemaker, C. F. Bennett, Cationic lipids enhance cellular uptake and activity of phosphorothioate antisense oligonucleotides. Molecular Pharmacology. ,vol. 41, pp. 1023- 1033 ,(1992)
Yasumasa Ito, Pramod Pandey, Michael B Sporn, Rakesh Datta, Surender Kharbanda, Donald Kufe, None, The novel triterpenoid CDDO induces apoptosis and differentiation of human osteosarcoma cells by a caspase-8 dependent mechanism. Molecular Pharmacology. ,vol. 59, pp. 1094- 1099 ,(2001) , 10.1124/MOL.59.5.1094